DFTX insider trading
Definium Therapeutics, Inc.
In the past 36 days, 5 insiders sold $2.3M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Robert Barrow Chief Executive Officer |
$1.2M 31,550 sh @ $36.57 |
−1.4% | Pre-scheduled | Sep 25, 2026 Filed Sep 29, 2026 |
Mark Sullivan Chief Legal Officer |
$514K 14,051 sh @ $36.57 |
−2.8% | Pre-scheduled | Sep 25, 2026 Filed Sep 29, 2026 |
Daniel Karlin Chief Medical Officer |
$397K 10,853 sh @ $36.57 |
−1.4% | Pre-scheduled | Sep 25, 2026 Filed Sep 29, 2026 |
Brandi Roberts Chief Financial Officer |
$123K 3,377 sh @ $36.57 |
−0.8% | Pre-scheduled | Sep 25, 2026 Filed Sep 29, 2026 |
Matthew T. Wiley Chief Commercial Officer |
$113K 3,097 sh @ $36.57 |
−0.9% | Pre-scheduled | Sep 25, 2026 Filed Sep 29, 2026 |